DENTSPLY SIRONA’s (XRAY) “In-Line” Rating Reiterated at Evercore ISI

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “in-line” rating reissued by Evercore ISI in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $20.00 target price on the medical instruments supplier’s stock. Evercore ISI’s target price would indicate a potential upside of 6.04% from the company’s current price.

A number of other research firms have also weighed in on XRAY. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Finally, Mizuho began coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Nine investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $27.27.

DENTSPLY SIRONA Stock Up 1.3 %

XRAY stock opened at $18.86 on Tuesday. The firm has a market cap of $3.75 billion, a PE ratio of -9.11, a P/E/G ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a 50 day simple moving average of $19.54 and a 200 day simple moving average of $23.26.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Nordea Investment Management AB grew its stake in shares of DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after buying an additional 178,639 shares in the last quarter. Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at approximately $342,000. GAMMA Investing LLC grew its position in DENTSPLY SIRONA by 155.5% in the fourth quarter. GAMMA Investing LLC now owns 6,357 shares of the medical instruments supplier’s stock worth $121,000 after acquiring an additional 3,869 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the last quarter. Finally, Synovus Financial Corp bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $240,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.